Diagnostic Imaging's Weekly Scan: February 8 — February 14

Welcome to Diagnostic Imaging’s Weekly Scan, which offers an opportunity to catch up on the most well-viewed radiology content of the past week.

Artificial intelligence scores > 73.5 percent for mammography were associated with over a threefold higher cumulative incidence rate for ipsilateral recurrence of DCIS in women treated with breast-conserving surgery, according to new research published in the American Journal of Roentgenology.

In the debut of our new Molecular Imaging in Focus series, Gary Ulaner, M.D., Ph.D., discussed preliminary research with the newly patented 61Cu-NU101 radiodiagnostic PET agent and the potential with the agent’s half-life in expanding access to molecular imaging for prostate cancer detection.

In another interview with Diagnostic Imaging, Benjamin Kann, M.D., discussed new research highlighting the capability of an AI foundation model to obtain a variety of diagnostic and prognostic data from brain MRI scans.

Total plaque volume > 87 mm3 derived from coronary computed tomography angiography (CCTA) was associated with double the risk for major adverse cardiovascular events (MACE), according to a study of over 4,200 symptomatic patients with an unknown history of coronary artery disease (CAD).

Earlier this week, the emerging SPECT/CT agent ⁹⁹mTc-maraciclatide received the FDA’s fast track designation for inflammation assessment in patients with known or suspected interstitial lung disease (ILD). Serac Healthcare, the developer of the SPECT/CT agent, said it may help enhance detection and differentiation for ILD, which is associated with a large variety of disorders.